Strain identifier
BacDive ID: 1952
Type strain:
Species: Burkholderia cenocepacia
Strain Designation: CF5610, J2315
Strain history: CIP <- 2004, CCUG <- 2003, LMG <- 1995, J. Govan, Edinburgh Univ., Edinburgh, UK: strain J2315
NCBI tax ID(s): 95486 (species)
General
@ref: 6505
BacDive-ID: 1952
DSM-Number: 16553
keywords: genome sequence, 16S sequence, Bacteria, obligate aerobe, mesophilic, Gram-negative, motile, rod-shaped, antibiotic resistance
description: Burkholderia cenocepacia CF5610 is an obligate aerobe, mesophilic, Gram-negative bacterium that has multiple antibiotic resistances and was isolated from sputum from cystic fibrosis patient.
NCBI tax id
- NCBI tax id: 95486
- Matching level: species
strain history
@ref | history |
---|---|
6505 | <- LMG; LMG 16656 <- J. Govan; CF5610 |
117244 | CIP <- 2004, CCUG <- 2003, LMG <- 1995, J. Govan, Edinburgh Univ., Edinburgh, UK: strain J2315 |
doi: 10.13145/bacdive1952.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/pseudomonadota
- domain: Bacteria
- phylum: Pseudomonadota
- class: Betaproteobacteria
- order: Burkholderiales
- family: Burkholderiaceae
- genus: Burkholderia
- species: Burkholderia cenocepacia
- full scientific name: Burkholderia cenocepacia Vandamme et al. 2003
@ref: 6505
domain: Bacteria
phylum: Proteobacteria
class: Betaproteobacteria
order: Burkholderiales
family: Burkholderiaceae
genus: Burkholderia
species: Burkholderia cenocepacia
full scientific name: Burkholderia cenocepacia Vandamme et al. 2003
strain designation: CF5610, J2315
type strain: yes
Morphology
cell morphology
- @ref: 117244
- gram stain: negative
- cell shape: rod-shaped
- motility: yes
colony morphology
- @ref: 6505
- incubation period: 1-2 days
Culture and growth conditions
culture medium
@ref | name | growth | link | composition |
---|---|---|---|---|
6505 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | yes | https://mediadive.dsmz.de/medium/693 | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
37374 | MEDIUM 72- for trypto casein soja agar | yes | Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g) | |
6505 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | yes | https://mediadive.dsmz.de/medium/92 | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
117244 | CIP Medium 72 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72 |
culture temp
@ref | growth | type | temperature | range |
---|---|---|---|---|
6505 | positive | growth | 30 | mesophilic |
37374 | positive | growth | 30 | mesophilic |
117244 | positive | growth | 25-41 | |
117244 | no | growth | 5 | psychrophilic |
117244 | no | growth | 10 | psychrophilic |
Physiology and metabolism
oxygen tolerance
- @ref: 117244
- oxygen tolerance: obligate aerobe
antibiogram
@ref | medium | incubation temperature | incubation time | oxygen condition | Penicillin G | oxacillin | ampicillin | ticarcillin | mezlocillin | cefalotin | cefazolin | cefotaxime | aztreonam | imipenem | tetracycline | chloramphenicol | gentamycin | amikacin | vancomycin | erythromycin | lincomycin | ofloxacin | norfloxacin | colistin | pipemidic acid | nitrofurantoin | bacitracin | polymyxin b | kanamycin | neomycin | doxycycline | ceftriaxone | clindamycin | fosfomycin | moxifloxacin | linezolid | nystatin | quinupristin/dalfopristin | teicoplanin | piperacillin/tazobactam |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6505 | Mueller-Hinton Agar | 30 | 1 | aerob | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 |
6505 | Mueller-Hinton Agar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
halophily
@ref | salt | growth | tested relation | concentration |
---|---|---|---|---|
117244 | NaCl | positive | growth | 0-6 % |
117244 | NaCl | no | growth | 8 % |
117244 | NaCl | no | growth | 10 % |
metabolite utilization
@ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
---|---|---|---|---|
68369 | 25115 | malate | + | assimilation |
68369 | 27689 | decanoate | + | assimilation |
68369 | 24265 | gluconate | + | assimilation |
68369 | 17306 | maltose | - | assimilation |
68369 | 59640 | N-acetylglucosamine | + | assimilation |
68369 | 16899 | D-mannitol | + | assimilation |
68369 | 16024 | D-mannose | + | assimilation |
68369 | 17634 | D-glucose | + | assimilation |
68369 | 5291 | gelatin | - | hydrolysis |
68369 | 4853 | esculin | - | hydrolysis |
68369 | 27897 | tryptophan | - | energy source |
68369 | 17632 | nitrate | - | reduction |
117244 | 4853 | esculin | - | hydrolysis |
117244 | 17632 | nitrate | - | reduction |
117244 | 16301 | nitrite | - | reduction |
117244 | 17632 | nitrate | - | respiration |
antibiotic resistance
- @ref: 117244
- metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
- is antibiotic: yes
- is sensitive: no
- is resistant: yes
metabolite production
@ref | Chebi-ID | metabolite | production |
---|---|---|---|
68369 | 35581 | indole | no |
117244 | 35581 | indole | no |
metabolite tests
- @ref: 68369
- Chebi-ID: 35581
- metabolite: indole
- indole test: -
enzymes
@ref | value | activity | ec |
---|---|---|---|
68382 | alpha-fucosidase | - | 3.2.1.51 |
68382 | alpha-mannosidase | - | 3.2.1.24 |
68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
68382 | beta-glucosidase | + | 3.2.1.21 |
68382 | alpha-glucosidase | - | 3.2.1.20 |
68382 | beta-glucuronidase | - | 3.2.1.31 |
68382 | beta-galactosidase | - | 3.2.1.23 |
68382 | alpha-galactosidase | - | 3.2.1.22 |
68382 | naphthol-AS-BI-phosphohydrolase | + | |
68382 | acid phosphatase | + | 3.1.3.2 |
68382 | alpha-chymotrypsin | - | 3.4.21.1 |
68382 | trypsin | - | 3.4.21.4 |
68382 | cystine arylamidase | - | 3.4.11.3 |
68382 | valine arylamidase | - | |
68382 | leucine arylamidase | + | 3.4.11.1 |
68382 | lipase (C 14) | - | |
68382 | esterase lipase (C 8) | + | |
68382 | esterase (C 4) | + | |
68382 | alkaline phosphatase | + | 3.1.3.1 |
68369 | gelatinase | - | |
68369 | beta-glucosidase | - | 3.2.1.21 |
117244 | oxidase | + | |
117244 | beta-galactosidase | + | 3.2.1.23 |
117244 | alcohol dehydrogenase | - | 1.1.1.1 |
117244 | gelatinase | - | |
117244 | amylase | - | |
117244 | DNase | - | |
117244 | caseinase | - | 3.4.21.50 |
117244 | catalase | + | 1.11.1.6 |
117244 | tween esterase | - | |
117244 | lecithinase | - | |
117244 | lipase | + | |
117244 | lysine decarboxylase | - | 4.1.1.18 |
117244 | ornithine decarboxylase | - | 4.1.1.17 |
117244 | protease | - | |
117244 | tryptophan deaminase | - | |
117244 | urease | - | 3.5.1.5 |
API zym
@ref | Control | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117244 | - | + | + | + | - | + | - | - | - | - | + | + | - | - | - | - | + | - | - | - |
API 20NE
@ref | NO3 | TRP | GLU_ Ferm | ADH Arg | URE | ESC | GEL | PNPG | GLU_ Assim | ARA | MNE | MAN | NAG | MAL | GNT | CAP | ADI | MLT | CIT | PAC | OX |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6505 | - | - | - | - | - | - | - | + | + | - | + | + | + | - | + | + | + | + | +/- | + | - |
6505 | - | - | - | - | - | - | - | + | + | +/- | + | + | + | - | + | + | + | + | + | + | + |
6505 | - | - | +/- | - | - | - | - | + | + | +/- | + | + | + | - | + | + | + | + | + | + | |
6505 | - | - | + | + | + | - | - | + | + | +/- | + | + | + | - | + | + | + | + | + | + | + |
6505 | - | - | - | - | - | - | - | + | + | +/- | + | + | + | - | + | + | +/- | + | + | + | + |
API biotype100
@ref | GLU | FRU | GAL | TRE | MNE | SBE | MEL | SAC | RAF | MTE | MAL | LAC | LTE | MbGa | MaGa | CEL | GEN | MbGu | ESC | RIB | ARA | XYL | PLE | RHA | FUC | MLZ | DARL | LARL | XLT | DUL | TAG | GLY | INO | MAN | MTL | TUR | SOR | ADO | HBG | LYX | ERY | MDG | 3MDG | SAT | MUC | LTAT | DTAT | MTAT | DMLT | LMLT | CATE | TATE | TTE | CIT | GRT | GAT | 2KG | 5KG | TRY | NAG | GNT | PAC | PAT | pOBE | QAT | GTE | mOBE | BAT | PPAT | CMT | TGE | BET | PCE | ABT | HIN | LAT | CAP | CYT | HIS | SUC | FUM | GRE | GYT | AVT | ETN | TTN | GLN | ITA | 3OBU | APT | GTT | PRO | DALA | LALA | SER | MNT | PROP | TYR | 2KT |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117244 | + | + | + | - | + | - | - | + | - | - | - | - | - | + | - | - | - | - | - | + | + | + | - | - | + | - | + | + | + | + | - | + | + | + | - | - | + | + | - | - | - | - | - | + | + | + | - | - | + | + | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | + | - | - | - | - | + | - | + | - | + | + | + | - | + | + | + | + | - | + | - | + | - | + | + | + | + | + | + | + | + | + | + | + |
Isolation, sampling and environmental information
isolation
@ref | sample type | geographic location | country | origin.country | continent | latitude | longitude | sampling date | isolation date |
---|---|---|---|---|---|---|---|---|---|
6505 | sputum from cystic fibrosis patient | Edinburgh | United Kingdom | GBR | Europe | 55.9533 | -3.1883 | ||
58156 | Human sputum,cystic fibrosis | Edinburgh | United Kingdom | GBR | Europe | 1989 | |||
117244 | Human, Sputum, cystic fibrosis | Edinburgh, Scotland | United Kingdom | GBR | Europe | 1989 |
isolation source categories
Cat1 | Cat2 | Cat3 |
---|---|---|
#Infection | #Disease | #Cystic fibrosis |
#Infection | #Patient | |
#Host Body Product | #Fluids | #Sputum |
Safety information
risk assessment
@ref | biosafety level | biosafety level comment |
---|---|---|
6505 | 2 | Risk group (German classification) |
117244 | 1 | Risk group (French classification) |
Sequence information
16S sequences
- @ref: 6505
- description: Burkholderia cepacia genomovar III 16S ribosomal RNA gene, partial sequence
- accession: AF148556
- length: 1408
- database: ena
- NCBI tax ID: 95486
Genome sequences
@ref | description | accession | assembly level | database | NCBI tax ID |
---|---|---|---|---|---|
66792 | Burkholderia cenocepacia NCTC13227 | GCA_900446215 | contig | ncbi | 95486 |
66792 | Burkholderia cenocepacia strain NCTC13227 | 95486.373 | wgs | patric | 95486 |
66792 | Burkholderia cepacia strain LMG 16656 | 292.25 | wgs | patric | 292 |
66792 | Burkholderia cepacia LMG 16656 | 2630968810 | draft | img | 292 |
Genome-based predictions
predictions
trait | prediction | confidence | training_data |
---|---|---|---|
motile | yes | 85.837 | no |
flagellated | no | 81.93 | no |
gram-positive | no | 97.995 | no |
anaerobic | no | 98.694 | no |
halophile | no | 91.448 | no |
spore-forming | no | 93.745 | no |
thermophile | no | 99.632 | no |
glucose-util | yes | 86.487 | no |
aerobic | yes | 90.587 | no |
glucose-ferment | no | 88.58 | no |
External links
@ref: 6505
culture collection no.: CIP 108255, DSM 16553, ATCC BAA 245, CCM 4899, CCUG 48434, LMG 16656, NCTC 13227
straininfo link
- @ref: 71597
- straininfo: 8887
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Phylogeny | 12648723 | Burkholderia cenocepacia sp. nov.--a new twist to an old story. | Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E, LiPuma JJ, Govan JR | Res Microbiol | 10.1016/S0923-2508(03)00026-3 | 2003 | Burkholderia/*classification/genetics, Burkholderia Infections/microbiology, Burkholderia cepacia/genetics, Cystic Fibrosis/microbiology, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Phylogeny, Rec A Recombinases/genetics, Sequence Analysis, DNA | Pathogenicity |
Genetics | 16737826 | Use of ribosomal promoters from Burkholderia cenocepacia and Burkholderia cepacia for improved expression of transporter protein in Escherichia coli. | Yu M, Tsang JS | Protein Expr Purif | 10.1016/j.pep.2006.04.004 | 2006 | Bacterial Proteins/*genetics, Burkholderia cepacia/*genetics, Carrier Proteins/biosynthesis/*genetics, *Escherichia coli/genetics/growth & development, Gene Expression, Promoter Regions, Genetic/*genetics, Recombinant Proteins/biosynthesis/genetics, Ribosomal Proteins/*genetics | |
Pathogenicity | 17219455 | The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). | Silipo A, Molinaro A, Ierano T, De Soyza A, Sturiale L, Garozzo D, Aldridge C, Corris PA, Khan CM, Lanzetta R, Parrilli M | Chemistry | 10.1002/chem.200601406 | 2007 | Burkholderia Infections/epidemiology/microbiology/*pathology, Burkholderia cepacia/genetics/immunology/*pathogenicity, Cystic Fibrosis/epidemiology/microbiology/*pathology, Disease Outbreaks, Humans, Inflammation/*pathology, Lipopolysaccharides/*chemistry/immunology/*pharmacology, Magnetic Resonance Spectroscopy, U937 Cells/drug effects/pathology, Virulence | |
Metabolism | 20852798 | Characterization of liposomes formed by lipopolysaccharides from Burkholderia cenocepacia, Burkholderia multivorans and Agrobacterium tumefaciens: from the molecular structure to the aggregate architecture. | D'Errico G, Silipo A, Mangiapia G, Vitiello G, Radulescu A, Molinaro A, Lanzetta R, Paduano L | Phys Chem Chem Phys | 10.1039/c0cp00066c | 2010 | Agrobacterium tumefaciens/*metabolism, Burkholderia/*metabolism, Burkholderia cenocepacia/metabolism, Electron Spin Resonance Spectroscopy, Light, Lipopolysaccharides/*chemistry, Liposomes/*chemistry, Neutron Diffraction, Phosphatidylethanolamines/chemistry, Scattering, Radiation, Scattering, Small Angle | |
Pathogenicity | 22322958 | Interaction of environmental Burkholderia cenocepacia strains with cystic fibrosis and non-cystic fibrosis bronchial epithelial cells in vitro. | Bevivino A, Pirone L, Pilkington R, Cifani N, Dalmastri C, Callaghan M, Ascenzioni F, McClean S | Microbiology (Reading) | 10.1099/mic.0.056986-0 | 2012 | Bronchi/cytology, Burkholderia Infections/*pathology, Burkholderia cenocepacia/*pathogenicity, Cell Line, Cystic Fibrosis/*microbiology, Epithelial Cells/*microbiology, Humans, Membrane Proteins/metabolism, Phosphoproteins/metabolism, Rhizosphere, Tight Junctions/microbiology, Zea mays/microbiology, Zonula Occludens-1 Protein | Metabolism |
Pathogenicity | 28587856 | Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia. | Vanhoutte B, Cappoen D, Maira BM, Cools F, Torfs E, Coenye T, Martinet W, Caljon G, Maes L, Delputte P, Cos P | J Microbiol Methods | 10.1016/j.mimet.2017.06.003 | 2017 | Animals, Anti-Bacterial Agents/administration & dosage/*therapeutic use, Burkholderia Infections/*drug therapy/immunology/microbiology, Burkholderia cenocepacia/*drug effects, Cytokines/biosynthesis, *Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Liver/microbiology, Lung/immunology/*microbiology/pathology, Mice, Mice, Inbred BALB C, Pneumonia/drug therapy/microbiology, Respiratory Tract Infections/*drug therapy/microbiology, Spleen/microbiology, Tobramycin/administration & dosage/*therapeutic use | |
Phenotype | 29135920 | Environmental Burkholderia cenocepacia Strain Enhances Fitness by Serial Passages during Long-Term Chronic Airways Infection in Mice. | Bragonzi A, Paroni M, Pirone L, Coladarci I, Ascenzioni F, Bevivino A | Int J Mol Sci | 10.3390/ijms18112417 | 2017 | Adaptation, Physiological, Animals, Bacterial Load, Biofilms, Burkholderia cenocepacia/pathogenicity/*physiology, Chronic Disease, Clone Cells, Colony Count, Microbial, *Environmental Microbiology, *Genetic Fitness, Kaplan-Meier Estimate, Larva/microbiology, Lung/microbiology/pathology, Mice, Mice, Inbred C57BL, Phenotype, Random Amplified Polymorphic DNA Technique, Respiratory Tract Infections/*microbiology, Serial Passage, Virulence |
Reference
@id | authors | catalogue | doi/url | title |
---|---|---|---|---|
6505 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 16553) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-16553 | |
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
37374 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/5857 | ||
58156 | Curators of the CCUG | Culture Collection University of Gothenburg (CCUG) (CCUG 48434) | https://www.ccug.se/strain?id=48434 | |
66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |
68369 | Automatically annotated from API 20NE | |||
68382 | Automatically annotated from API zym | |||
71597 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID8887.1 | StrainInfo: A central database for resolving microbial strain identifiers | |
117244 | Curators of the CIP | Collection of Institut Pasteur (CIP 108255) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20108255 |